Androgens, Endometriosis and Pain
- PMID: 36303965
- PMCID: PMC9580713
- DOI: 10.3389/frph.2021.792920
Androgens, Endometriosis and Pain
Abstract
The intriguing relationship between androgens, endometriosis and chronic pain continues to unfold. Determining this relationship is of crucial importance to gynecologists managing people with these conditions, as common treatments dramatically alter her hormonal profiles, with both intended and unintended consequences. Although they may be present in the same individual, there is a recognized disconnect between pain or pain-related symptoms, and the presence or extent of endometriosis lesions. Reduced androgen levels provide a potential mechanism to link the development of endometriosis lesions and the presence of chronic pain. This research paper expands the presentation of our research at the World Endometriosis Congress in 2021, subsequently published in the Journal of Pain Research which demonstrated a strong inverse relationship between androgen levels and days per month of pelvic and period pain. Here we extend and further explore the evidence for a role for androgens in the etiology and management of dysmenorrhea and pelvic pain in women, both with and without endometriosis. We explore the potential for inflammation to induce low androgen levels and consider ways in which clinicians can optimize levels of androgens when treating women with these conditions. This article prompts the question: Is it estrogens that predispose people to a life of pain, or androgens that are protective?
Keywords: androgen; aromatase inhibitor; chronic pain; endometriosis; hormonal; immune; testosterone; women.
Copyright © 2021 Evans, Hull, Hutchinson and Rolan.
Conflict of interest statement
SE receives royalties from book authorship, is a shareholder in Alyra Biotech Pty Ltd a company developing non-hormonal immune therapies for pelvic pain and Havah Therapeutics Pty Ltd a company developing testosterone therapies for women with breast cancer; and has patents pending: PCT/AU2018/051383 and PCT/AU2020/050551, Alyra Biotech Pty Ltd. PR is a shareholder in Havah Therapeutics, Alyra Biotech, Lipotek and iX Biopharma, a consultant to Bionomics and Novartis, and has received payment for educational presentations from Novartis and Seqirus. MRH is Director of the Australian Research Council Centre of Excellence for Nanoscale BioPhotonics CE140100003 and the recipient of an ARC Future Fellowship FT180100565, and reports grants from Australian Research Council, National Health and Medical Research Council, Meat and Livestock Australia, Air Force Office of Scientific Research, Defence Science Technology Group, and National Institutes of Health. His research program is supported by Novartis, Abbott, Pfizer and Regeneus, but these activities fall outside the submitted work. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
The comorbidities of dysmenorrhea: a clinical survey comparing symptom profile in women with and without endometriosis.J Pain Res. 2018 Dec 13;11:3181-3194. doi: 10.2147/JPR.S179409. eCollection 2018. J Pain Res. 2018. PMID: 30588070 Free PMC article.
-
Aromatase as a target for treating endometriosis.J Obstet Gynaecol Res. 2018 Sep;44(9):1673-1681. doi: 10.1111/jog.13743. Epub 2018 Jul 25. J Obstet Gynaecol Res. 2018. PMID: 30043503 Review.
-
ACOG Committee Opinion No. 760: Dysmenorrhea and Endometriosis in the Adolescent.Obstet Gynecol. 2018 Dec;132(6):e249-e258. doi: 10.1097/AOG.0000000000002978. Obstet Gynecol. 2018. PMID: 30461694
-
ACOG Committee Opinion No. 760 Summary: Dysmenorrhea and Endometriosis in the Adolescent.Obstet Gynecol. 2018 Dec;132(6):1517-1518. doi: 10.1097/AOG.0000000000002981. Obstet Gynecol. 2018. PMID: 30461690
-
Management of the pain associated with endometriosis: an update of the painful problems.Tohoku J Exp Med. 2006 Nov;210(3):175-88. doi: 10.1620/tjem.210.175. Tohoku J Exp Med. 2006. PMID: 17077594 Review.
Cited by
-
Prenatal Origins of Endometriosis Pathology and Pain: Reviewing the Evidence of a Role for Low Testosterone.J Pain Res. 2023 Feb 3;16:307-316. doi: 10.2147/JPR.S389166. eCollection 2023. J Pain Res. 2023. PMID: 36762368 Free PMC article.
-
Molecular Profile (Estrogen Receptor, Progesterone Receptor, Bcl-2 and Ki-67) of the Ectopic Endometrium in Patients with Endometriosis.Int J Mol Sci. 2025 Mar 25;26(7):2983. doi: 10.3390/ijms26072983. Int J Mol Sci. 2025. PMID: 40243611 Free PMC article.
-
Smoking and endometriosis: A narrative review.Tob Induc Dis. 2025 Jun 26;23. doi: 10.18332/tid/203429. eCollection 2025. Tob Induc Dis. 2025. PMID: 40575735 Free PMC article. Review.
-
Premenopausal Syndrome and NAFLD: A New Approach Based on Gender Medicine.Biomedicines. 2022 May 20;10(5):1184. doi: 10.3390/biomedicines10051184. Biomedicines. 2022. PMID: 35625920 Free PMC article. Review.
-
Androgen signalling in the ovaries and endometrium.Mol Hum Reprod. 2023 May 31;29(6):gaad017. doi: 10.1093/molehr/gaad017. Mol Hum Reprod. 2023. PMID: 37171897 Free PMC article. Review.
References
-
- Evans SF, Kwok Y, Solterbeck A, Pyragius C, Hull ML, Hutchinson MR, et al. . The relationship between androgens and days per month of period pain, pelvic pain, headache, and TLR4 responsiveness of peripheral blood mononuclear cells in young women with dysmenorrhoea. J Pain Res. (2021) 14:585–99. 10.2147/JPR.S279253 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources